Lanolin
drug drugOn this page
Also known as Adeps lanaeAnhydrous lanolinEmery 1600EuceriteLanolin - anhydrousLanolin anhydrousanhydrousanhydrous liquidOvis ariesPurified lanolinSuintineWool fatWool greaseWool wax
Summary
Lanolin (CHEMBL2108387) is a phase-3 clinical-stage unknown.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Unknown
- Clinical trials: 3
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2108387 |
| Name | Lanolin |
| Type | Unknown |
| Max phase | 3 |
Also known as: Adeps lanae, Anhydrous lanolin, Emery 1600, Eucerite, Lanolin, Lanolin - anhydrous, Lanolin anhydrous, anhydrous, anhydrous liquid, Ovis aries, Purified lanolin, Suintine
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.
Clinical trials
Total trials: 3.
Phase distribution
| Phase | Trials |
|---|---|
| PHASE4 | 2 |
| PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT01420419 | PHASE4 | COMPLETED | Evaluating Lanolin for the Treatment of Nipple Pain Among Breastfeeding Women |
| NCT03389516 | PHASE4 | UNKNOWN | Healing Nipple Wounds: Comparison Between 2 Treatment Modalities |
| NCT04153513 | PHASE2 | COMPLETED | Effect of Lanolin and Breastmilk in the Treatment of Sore and Damaged Nipples in Breastfeeding Women |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.